​

Funding Round

Venture Round - Remix Therapeutics

Venture Round - Remix Therapeutics

Investment Firm

Overview

Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.

Announced Date

Jan 03, 2024

Closed on Date

Jan 03, 2024

Funding Type

Series Unknown

Highlights

Location

United States, North America

Social

Investor Lead

The Column Group

The Column Group

The Column Group is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed firm.

Participant Investors

6

Investor Name
Participant InvestorCasdin Capital
Participant InvestorForesite Capital
Participant InvestorThe Column Group
Participant InvestorAtlas Venture
Participant InvestorARCH Venture Partners

Round Details and Background

Remix Therapeutics raised $60000000 on 2024-01-03 in Venture Round

Remix Therapeutics is a biotechnology company that is working on developing small molecule medicines.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 08, 2020
Series A - Remix Therapeutics
5-65.0M
Jan 01, 2019
Seed Round - Remix Therapeutics
2-16.0M
May 17, 2022
Series B - Remix Therapeutics
7-70.0M
Jan 03, 2024
Venture Round - Remix Therapeutics
9-60.0M

Recent Activity

There is no recent news or activity for this profile.